← Back to Search

Platinum-based Chemotherapy

Treatment for Large Cell Carcinoma

Phase 2
Waitlist Available
Led By Sang Byung Bae, M.D.
Research Sponsored by Korean South West Oncology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2years
Awards & highlights

Summary

1. Goals The primary goal of this phase II trial is to: evaluate the response rate of combination chemotherapy with docetaxel and oxaliplatin in patients with stage IIIB/IV non-adenocarcinoma, non-small cell lung cancer (NSCLC) as second-line treatment Secondary goals are to: evaluate the treatment-related toxicities of this combination, investigate progression-free survival (PFS) and overall survival (OS) in this population 2. Design The proposed clinical trial is an open label, non-comparative, multicenter phase II trial according to the two stage testing design by Simon two-stage testing procedure

Eligible Conditions
  • Large Cell Carcinoma
  • Squamous Cell Carcinoma
  • Non-Small Cell Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Response rate
Secondary study objectives
Number of Participants with Adverse Events
Overall survival
Progression free survival
+1 more

Find a Location

Who is running the clinical trial?

Korean South West Oncology GroupLead Sponsor
3 Previous Clinical Trials
111 Total Patients Enrolled
Sang Byung Bae, M.D.Principal InvestigatorSoonchunhyang University Hospital
~2 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top